Literature DB >> 30149034

Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects.

Emily Carias1, Dennis Fricke1, Abisha Vijayashanthar1, Lauren Smith1, Rathini Somanesan1, Connor Martin1, Leanna Kalinowski1, Daniel Popoola1, Michael Hadjiargyrou2, David E Komatsu3, Panayotis K Thanos4.   

Abstract

Methylphenidate (MP) is a commonly prescribed psychostimulant for Attention Deficit Hyperactivity Disorder (ADHD). We recently reported behavioral and developmental effects of chronic MP use in healthy rats. The current study investigated how interrupting chronic MP treatment with weekend abstinence altered the behavioral and physiological consequences of chronic MP treatment, and if prolonged abstinence would reverse the observed effects. Male Sprague Dawley rats were assigned to one of three treatment groups: water (W); low dose (LD) MP; and high dose (HD) MP. For 13 weeks, rats had access to drink from a bottle containing 4 mg/kg MP (LD), 30 mg/kg MP (HD) or water (W) for 1 h, and 10 mg/kg MP (LD), 60 mg/kg MP (HD) or water (W) for the next 7 h, each week day. During weekends, all animals received only water as well as throughout the 5-week-long abstinence phase, which immediately followed the treatment phase. Throughout the treatment phase, regardless of weekend abstinence, chronic MP resulted in significant decreased food and fluid intake and body weight. Also, HD MP exposure resulted in the following behavioral effects: increased open field and circadian locomotor activity; increased latency to immobility and decreased time spent immobile in the forced swim test; increased center activity in the open field and percent of time spent in an open arm of the elevated-plus-maze; and increased social affiliation and memory in the Crawley's three chamber sociability test. During the prolonged (5-week) abstinence phase, all these effects were reversed while HD treated rats increased their fluid intake. These results indicated that intermittent brief abstinence periods (weekend's off-treatment) produced the same behavioral and developmental effects as those previously reported with chronic (7 days/week) MP treatment, but were reversible following a prolonged abstinence period (5 weeks).
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Attention Deficit Hyperactivity Disorder; Depression; Methylphenidate; Psychostimulant; Ritalin; Social behavior

Mesh:

Substances:

Year:  2018        PMID: 30149034      PMCID: PMC6317517          DOI: 10.1016/j.bbr.2018.08.014

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  44 in total

1.  What are the long-term effects of methylphenidate treatment?

Authors:  Nora D Volkow; Thomas R Insel
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

2.  Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences.

Authors:  Stefanie Mache; Patrick Eickenhorst; Karin Vitzthum; Burghard F Klapp; David A Groneberg
Journal:  Wien Med Wochenschr       Date:  2012-06-16

3.  Genetic differences in responses to cocaine.

Authors:  F R George; S R Goldberg
Journal:  NIDA Res Monogr       Date:  1988

Review 4.  Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse.

Authors:  Ronald Kuczenski; David S Segal
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

5.  The effect of methylphenidate on anxiety and depression symptoms in patients with Asperger syndrome and comorbid attention deficit/hyperactivity disorder.

Authors:  Pavel Golubchik; Michal Rapaport; Abraham Weizman
Journal:  Int Clin Psychopharmacol       Date:  2017-09       Impact factor: 1.659

6.  The multifaceted effects of oral administration of methylphenidate in juvenile rats: anxiety, activity, and attention.

Authors:  Ning Zhu; Jeremy Weedon; Diana L Dow-Edwards
Journal:  Eur Neuropsychopharmacol       Date:  2010-01-18       Impact factor: 4.600

7.  Methylphenidate Abuse and Psychiatric Side Effects.

Authors:  W Alexander Morton; Gwendolyn G. Stockton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10

8.  Differential effects of early stimulation and/or perinatal flumazenil treatment in young Roman low- and high-avoidance rats.

Authors:  A Fernández-Teruel; R M Escorihuela; P Driscoll; A Tobeña; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Brain Behav       Date:  2012-07-23       Impact factor: 2.708

10.  Stimulant use in medical students and residents requires more careful attention.

Authors:  Golnaz Fallah; Sussan Moudi; Angela Hamidia; Ali Bijani
Journal:  Caspian J Intern Med       Date:  2018
View more
  2 in total

1.  Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects.

Authors:  Leanna Kalinowski; Carly Connor; Rathini Somanesan; Emily Carias; Kaleigh Richer; Lauren Smith; Connor Martin; Macauley Mackintosh; Daniel Popoola; Michael Hadjiargyrou; David E Komatsu; Panayotis K Thanos
Journal:  Dev Psychobiol       Date:  2019-08-27       Impact factor: 3.038

2.  Fluoxetine Potentiates Oral Methylphenidate-Induced Gene Regulation in the Rat Striatum.

Authors:  Connor Moon; Matt Marion; Panayotis K Thanos; Heinz Steiner
Journal:  Mol Neurobiol       Date:  2021-07-02       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.